Crucell N.V. - SWOT, Strategy and Corporate Finance Report
Published: December 2012 · Publisher: MarketLine
Crucell N.V. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Crucell N.V. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Crucell N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Crucell N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Crucell N.V. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Crucell N.V.
- Intelligence on Crucell N.V.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Crucell N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Crucell (or ‘the company’), a Johnson & Johnson (J&J) company, is a global provider of vaccines and antibodies for the treatment of infectious diseases. The company's product portfolio is focused on three distinct areas: pediatric, travel and endemic, and respiratory. Crucell primarily operates in Europe, North America and Asia. It is headquartered in Leiden, the Netherlands and employs about 1,400 people. J&J, a US-based leading global healthcare company, completed the acquisition of Crucell for $2.3 billion in February 2011. Subsequently, Crucell became a wholly-owned subsidiary of J&J. Crucell has not released its financial statements for the financial year ended December 31, 2011 (FY2011). Hence, the company's financial details including revenues, operating and net profits are not available.
Reasons to Purchase:
- Gain understanding of Crucell N.V. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Crucell N.V. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Crucell N.V.’s business structure, strategy and prospects
Features:
- Detailed information on Crucell N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Crucell N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Crucell N.V. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Crucell N.V.
- Intelligence on Crucell N.V.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Crucell N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Crucell (or ‘the company’), a Johnson & Johnson (J&J) company, is a global provider of vaccines and antibodies for the treatment of infectious diseases. The company's product portfolio is focused on three distinct areas: pediatric, travel and endemic, and respiratory. Crucell primarily operates in Europe, North America and Asia. It is headquartered in Leiden, the Netherlands and employs about 1,400 people. J&J, a US-based leading global healthcare company, completed the acquisition of Crucell for $2.3 billion in February 2011. Subsequently, Crucell became a wholly-owned subsidiary of J&J. Crucell has not released its financial statements for the financial year ended December 31, 2011 (FY2011). Hence, the company's financial details including revenues, operating and net profits are not available.
Reasons to Purchase:
- Gain understanding of Crucell N.V. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Crucell N.V. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Crucell N.V.’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Crucell N.V.: Company Overview
Crucell N.V.: Overview and Key Facts
Crucell N.V.: Overview
Crucell N.V.: Key Facts
Crucell N.V.: Major Products and Services
Crucell N.V.: Company History
Crucell N.V.: Management Statement
Crucell N.V.: Locations and Subsidiaries
Crucell N.V.: Key Competitors
Crucell N.V.: Company Analysis
Crucell N.V.: Business Description
Crucell N.V.: SWOT Analysis
Crucell N.V.: SWOT Overview
Crucell N.V.: Strengths
Crucell N.V.: Weaknesses
Crucell N.V.: Opportunities
Crucell N.V.: Threats
Crucell N.V.: Corporate Financial Deals Activity
Crucell N.V.: Financial Deals Overview
Crucell N.V.: Targets and Partners
Crucell N.V.: Top Deals 2008 - 2012YTD*
Crucell N.V.: Advisors
Crucell N.V.: Top Legal Advisors
Crucell N.V.: Top Financial Advisors
Crucell N.V.: Mergers and Acquisitions
Crucell N.V.: Capital Raising
Crucell N.V.: Partnership
Crucell N.V.: Divestments
Crucell N.V.: Private Equity and Ownership
Crucell N.V.: Recent Developments
Crucell N.V.: News and Events Summary
Crucell N.V.: Business Expansion
Crucell N.V.: Financial Deals
Crucell N.V.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Crucell N.V.: Key Facts
Table 3: Crucell N.V.: Key Competitors
Table 4: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Crucell N.V.: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 6: Crucell N.V.: Targets and Partners
Table 7: Crucell N.V.: Top Deals 2008 - 2012YTD*
Table 8: Crucell N.V.: Legal Advisor Ranking by Value (US$m)
Table 9: Crucell N.V.: Financial Advisor Ranking by Value (US$m)
Table 10: Crucell N.V.: M&A Volume and Value Trend (2008 - YTD*2012)
Table 11: Crucell N.V.: M&A Activity by Geography (2008 - YTD*2012)
Table 12: Crucell N.V.: Capital Raising Volume and Value Trend (2008 - YTD*2012)
Table 13: Crucell N.V.: Capital Raising by Deal Type (2008 - YTD*2012)
Table 14: Crucell N.V.: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 15: Crucell N.V.: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 16: Crucell N.V.: Divestments Volume and Value Trend (2008 - YTD*2012)
Table 17: Crucell N.V.: Divestments by Geography (2008 - YTD*2012)
Table 18: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD*2012)
Table 19: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD*2012)
Table 20: Crucell N.V.: News and Events Summary
Table 21: Crucell N.V.: Business Expansion
Table 22: Crucell N.V.: Financial Deals
Table 23: Crucell N.V.: Research & Development
List of Figures
Figure 1: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Crucell N.V.: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Figure 3: Crucell N.V.: M&A Volume and Value Trend (2008 - YTD*2012)
Figure 4: Crucell N.V.: M&A Activity by Geography (2008 - YTD*2012)
Figure 5: Crucell N.V.: Capital Raising Volume and Value Trend (2008 - YTD*2012)
Figure 6: Crucell N.V.: Capital Raising by Deal Type (2008 - YTD*2012)
Figure 7: Crucell N.V.: Partnership Volume and Value Trend (2008 - YTD*2012)
Figure 8: Crucell N.V.: Partnership Trend by Deal Type (2008 - YTD*2012)
Figure 9: Crucell N.V.: Divestments Volume and Value Trend (2008 - YTD*2012)
Figure 10: Crucell N.V.: Divestments by Geography (2008 - YTD*2012)
Figure 11: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD*2012)
Figure 12: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD*2012)
Crucell N.V.: Company Overview
Crucell N.V.: Overview and Key Facts
Crucell N.V.: Overview
Crucell N.V.: Key Facts
Crucell N.V.: Major Products and Services
Crucell N.V.: Company History
Crucell N.V.: Management Statement
Crucell N.V.: Locations and Subsidiaries
Crucell N.V.: Key Competitors
Crucell N.V.: Company Analysis
Crucell N.V.: Business Description
Crucell N.V.: SWOT Analysis
Crucell N.V.: SWOT Overview
Crucell N.V.: Strengths
Crucell N.V.: Weaknesses
Crucell N.V.: Opportunities
Crucell N.V.: Threats
Crucell N.V.: Corporate Financial Deals Activity
Crucell N.V.: Financial Deals Overview
Crucell N.V.: Targets and Partners
Crucell N.V.: Top Deals 2008 - 2012YTD*
Crucell N.V.: Advisors
Crucell N.V.: Top Legal Advisors
Crucell N.V.: Top Financial Advisors
Crucell N.V.: Mergers and Acquisitions
Crucell N.V.: Capital Raising
Crucell N.V.: Partnership
Crucell N.V.: Divestments
Crucell N.V.: Private Equity and Ownership
Crucell N.V.: Recent Developments
Crucell N.V.: News and Events Summary
Crucell N.V.: Business Expansion
Crucell N.V.: Financial Deals
Crucell N.V.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Crucell N.V.: Key Facts
Table 3: Crucell N.V.: Key Competitors
Table 4: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Crucell N.V.: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 6: Crucell N.V.: Targets and Partners
Table 7: Crucell N.V.: Top Deals 2008 - 2012YTD*
Table 8: Crucell N.V.: Legal Advisor Ranking by Value (US$m)
Table 9: Crucell N.V.: Financial Advisor Ranking by Value (US$m)
Table 10: Crucell N.V.: M&A Volume and Value Trend (2008 - YTD*2012)
Table 11: Crucell N.V.: M&A Activity by Geography (2008 - YTD*2012)
Table 12: Crucell N.V.: Capital Raising Volume and Value Trend (2008 - YTD*2012)
Table 13: Crucell N.V.: Capital Raising by Deal Type (2008 - YTD*2012)
Table 14: Crucell N.V.: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 15: Crucell N.V.: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 16: Crucell N.V.: Divestments Volume and Value Trend (2008 - YTD*2012)
Table 17: Crucell N.V.: Divestments by Geography (2008 - YTD*2012)
Table 18: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD*2012)
Table 19: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD*2012)
Table 20: Crucell N.V.: News and Events Summary
Table 21: Crucell N.V.: Business Expansion
Table 22: Crucell N.V.: Financial Deals
Table 23: Crucell N.V.: Research & Development
List of Figures
Figure 1: Crucell N.V.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Crucell N.V.: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Figure 3: Crucell N.V.: M&A Volume and Value Trend (2008 - YTD*2012)
Figure 4: Crucell N.V.: M&A Activity by Geography (2008 - YTD*2012)
Figure 5: Crucell N.V.: Capital Raising Volume and Value Trend (2008 - YTD*2012)
Figure 6: Crucell N.V.: Capital Raising by Deal Type (2008 - YTD*2012)
Figure 7: Crucell N.V.: Partnership Volume and Value Trend (2008 - YTD*2012)
Figure 8: Crucell N.V.: Partnership Trend by Deal Type (2008 - YTD*2012)
Figure 9: Crucell N.V.: Divestments Volume and Value Trend (2008 - YTD*2012)
Figure 10: Crucell N.V.: Divestments by Geography (2008 - YTD*2012)
Figure 11: Crucell N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD*2012)
Figure 12: Crucell N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD*2012)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.